Perioperative blood conservation strategies for major spine surgery

Best Pract Res Clin Anaesthesiol. 2016 Mar;30(1):41-52. doi: 10.1016/j.bpa.2015.11.007. Epub 2015 Nov 28.

Abstract

Background: Orthopedic surgery, especially spine and spinal deformity surgery, may be associated with high perioperative blood loss. In order to reduce the risk of excessive blood loss and unnecessary blood transfusions, strategies such as Patient Blood Management including goal-directed coagulation management have been developed.

Recent findings: Adverse effects of allogeneic blood transfusions have been shown for most surgical fields including orthopedic surgery. Several efforts have been made to increase the preoperative red blood cell (RBC) mass, to reduce the intraoperative blood loss, and to use restrictive transfusion triggers in order to minimize or avoid RBC transfusions. Measures to reduce intraoperative blood loss include new surgical techniques, use of cell salvage where possible, bedside coagulation management with point-of-care devices, substitution of coagulation factors, antifibrinolytic agents, and desmopressin, induced hypotension, and avoidance of hypothermia.

Summary: Blood conservation in spinal surgery is a multidisciplinary approach and the efficacy of most single measures has been shown. Cost-effectiveness and the benefits of long-term patient outcomes are the subjects of current and future research.

Keywords: Patient Blood Management; ROTEM(®); goal-directed transfusions; spinal deformity surgery; spine surgery; thrombelastometry; transfusion management.

Publication types

  • Review

MeSH terms

  • Antifibrinolytic Agents
  • Blood Coagulation Factors / administration & dosage
  • Blood Loss, Surgical / prevention & control*
  • Blood Transfusion / methods
  • Erythrocyte Transfusion / adverse effects
  • Erythrocyte Transfusion / methods
  • Humans
  • Orthopedic Procedures / methods*
  • Perioperative Care / methods
  • Point-of-Care Systems
  • Spinal Diseases / surgery
  • Spine / surgery*
  • Transfusion Reaction

Substances

  • Antifibrinolytic Agents
  • Blood Coagulation Factors